{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T02:12:28Z","timestamp":1649124748265},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1996,10,1]],"date-time":"1996-10-01T00:00:00Z","timestamp":844128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1996,10]]},"DOI":"10.1007\/bf01806158","type":"journal-article","created":{"date-parts":[[2005,6,27]],"date-time":"2005-06-27T23:28:18Z","timestamp":1119914898000},"page":"307-313","source":"Crossref","is-referenced-by-count":9,"title":["Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancer"],"prefix":"10.1007","volume":"39","author":[{"given":"E. G. E.","family":"de Vries","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Rodenhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. C.","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. S. G. J.","family":"Hupperets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. V.","family":"Dolsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. V.","family":"Lebesque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. H.","family":"Blijham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bontenbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. H.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01806158_CR1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.1992.10.4.657","volume":"10","author":"DM Eddy","year":"1992","unstructured":"Eddy DM: High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer. J Clin Oncol 10: 657\u2013670, 1992","journal-title":"J Clin Oncol"},{"key":"BF01806158_CR2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0277-5379(91)90261-B","volume":"27","author":"G Falkson","year":"1991","unstructured":"Falkson G, Tormey DC, Carey P, Witte R, Falkson HC: Long-term survival of patients treated with combination chemotherapy for metastatic breast cancer. Eur J Cancer 27: 973\u2013977, 1991","journal-title":"Eur J Cancer"},{"key":"BF01806158_CR3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.7326\/0003-4819-91-6-847","volume":"91","author":"SS Legha","year":"1979","unstructured":"Legha SS, Buzdar AU, Smith TL, Hortobagyi GN, Swenerton KD, Blumenschein GR, Gehan EA, Bodey GP, Freireich EJ: Complete remission in metastatic breast cancer treated with combination drug therapy. Ann Int Med 91: 847\u2013852, 1979","journal-title":"Ann Int Med"},{"key":"BF01806158_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF01806548","volume":"13","author":"R Mick","year":"1989","unstructured":"Mick R, Begg CB, Antman KH, Korzun AH, Frei E III: Diverse prognosis in metastatic breast cancer: who should be offered alternative initial therapies? Breast Cancer Res Treat 13: 33\u201338, 1989","journal-title":"Breast Cancer Res Treat"},{"key":"BF01806158_CR5","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1200\/JCO.1991.9.12.2153","volume":"9","author":"G Falkson","year":"1991","unstructured":"Falkson G, Gelman R, Falkson CI, Glick J, Harris J: Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study. J Clin Oncol 9: 2153\u20132163, 1991","journal-title":"J Clin Oncol"},{"key":"BF01806158_CR6","first-page":"4654","volume":"49","author":"POM Mulder","year":"1989","unstructured":"Mulder POM, Sleijfer DTh, Willemse PHB, De Vries EGE, Uges DRA, Mulder NH: High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors. Cancer Res 49: 4654\u20134658, 1989","journal-title":"Cancer Res"},{"key":"BF01806158_CR7","unstructured":"WHO Handbook for Reporting Results of Cancer Treatment: WHO Offset Publication no. 48, Nijhoff, Den Haag, 1979"},{"key":"BF01806158_CR8","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/1097-0142(19891115)64:10<2045::AID-CNCR2820641013>3.0.CO;2-H","volume":"64","author":"POM Mulder","year":"1989","unstructured":"Mulder POM, Bouman JG, Gietema JA, Van Rijsbergen H, Mulder NH, Van der Geest S, De Vries EGE: Hyperalimentation in autologous bone marrow transplantation for solid tumors: comparison of total parenteral versus partial parenteral plus enteral nutrition. Cancer 64: 2045\u20132052, 1989","journal-title":"Cancer"},{"key":"BF01806158_CR9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457\u2013481, 1958","journal-title":"J Am Stat Assoc"},{"key":"BF01806158_CR10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/thx.47.2.136","volume":"47","author":"LT Vlasveld","year":"1992","unstructured":"Vlasveld LT, Delemarre JFM, Beijnen JH, Rodenhuis S: Invasive aspergillosis complicated by subclavian artery occlusion and costal osteomyelitis after autologous bone marrow transplantation. Thorax 47: 136\u2013137, 1992","journal-title":"Thorax"},{"key":"BF01806158_CR11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0277-5379(82)90073-6","volume":"18","author":"J Fischer","year":"1982","unstructured":"Fischer J, Rose CJ, Rubens RD: Duration of complete response to chemotherapy in advanced breast cancer. Eur J Cancer Clin Oncol 18: 747\u2013754, 1982","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF01806158_CR12","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1200\/JCO.1992.10.11.1743","volume":"10","author":"SF Williams","year":"1992","unstructured":"Williams SF, Gilewski T, Mick R, Bitran JD: High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report. J Clin Oncol 10: 1743\u20131747, 1992","journal-title":"J Clin Oncol"},{"key":"BF01806158_CR13","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/jnci\/83.13.920","volume":"83","author":"MJ Kennedy","year":"1991","unstructured":"Kennedy MJ, Beveridge RA, Rowley SD, Gordon GB, Abeloff MD, Davidson NE: High-dose chemotherapy with reinfusion of purged autologous bone marrow following doseintense induction as initial therapy for metastatic breast cancer. J Natl Cancer Inst 83: 920\u2013926, 1991","journal-title":"J Natl Cancer Inst"},{"key":"BF01806158_CR14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1200\/JCO.1994.12.1.37","volume":"12","author":"LJ Ayash","year":"1994","unstructured":"Ayash LJ, Elias A, Wheeler C, Reich E, Schwartz G, Tepler I, Warren D, Lynch C, Gonin R: Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study. J Clin Oncol 12: 37\u201344, 1994","journal-title":"J Clin Oncol"},{"key":"BF01806158_CR15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1200\/JCO.1994.12.7.1497","volume":"12","author":"RO Dillman","year":"1994","unstructured":"Dillman RO, Barth NM: Intensive chemotherapy with autologous peripheral blood stem-cell rescue in metastatic breast cancer. J Clin Oncol 12: 22\u201337, 1994","journal-title":"J Clin Oncol"},{"key":"BF01806158_CR16","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1200\/JCO.1988.6.9.1368","volume":"6","author":"WP Peters","year":"1988","unstructured":"Peters WP, Shpall EJ, Jones RB, Olsen GA, Bast RC, Gockerman JP, Moore JO: High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 6: 1368\u20131376, 1988","journal-title":"J Clin Oncol"},{"key":"BF01806158_CR17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0360-3016(94)90530-4","volume":"30","author":"AJ Mundt","year":"1994","unstructured":"Mundt AJ, Sibley GS, Williams S, Rubin SJ, Heimann R, Halpern H, Weichselbaum RR: Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy. Int J Radiation Oncol Biol Phys 30: 151\u2013160, 1994","journal-title":"Int J Radiation Oncol Biol Phys"},{"key":"BF01806158_CR18","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1200\/JCO.1995.13.8.2043","volume":"13","author":"LJ Ayash","year":"1995","unstructured":"Ayash LJ, Wheeler C, Fairclough D, Schwartz G, Reich E, Warren D, Schnipper L, Antman K, Frei E, Elias A: Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem cell support for advanced breast cancer. J Clin Oncol 13: 2034\u20132049, 1995","journal-title":"J Clin Oncol"},{"key":"BF01806158_CR19","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/1097-0142(19940415)73:8<2157::AID-CNCR2820730821>3.0.CO;2-1","volume":"73","author":"FR Dunphy","year":"1994","unstructured":"Dunphy FR, Spitzer G, Fornoff JE, Yau JC, Huan SD, Dicke KA, Buzdar AU, Hortobagyi GN: Factors predicting longterm survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support. Cancer 73: 2157\u20132167, 1994","journal-title":"Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01806158\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T13:50:31Z","timestamp":1557496231000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01806158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,10]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,10]]}},"alternative-id":["BF01806158"],"URL":"https:\/\/doi.org\/10.1007\/bf01806158","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,10]]}}}